Delivery of cell cycle genes to block astrocytoma growth.

作者: J. Fueyo , C. Gomez-Manzano , T.-J Liu , W.K. Alfred Yung

DOI: 10.1023/A:1010661131403

关键词:

摘要: Current therapies for glioblastoma multiforme are ineffective. Therefore, novel that target specific differences between normal and malignant cells urgently needed. Abnormalities of cell-cycle related genes a common feature cancer in general astrocytic tumors particular. The role these proteins is to help regulate cell proliferation, differentiation apoptosis. Restoring wild-type activity critical regulators the cycle generally results modification growth properties, often viability, cells. Transfer p53 induces arrest and, more importantly, Restoration Rb pathway either reversible or senescence. Expression E2F-1 transient increase proliferation followed by massive Overexpression MMAC/PTEN arrests progression G1 promotes anoikis. knowledge functions controllers can be used design small peptides drugs induce anti-cancer effect. Inactivation pathways also being engineer mutant viruses able replicate exclusively

参考文章(91)
N. Dyson, E. D. Harlow, Adenovirus E1A targets key regulators of cell proliferation. Cancer surveys. ,vol. 12, pp. 161- 195 ,(1992)
Behnam Badie, Mark H. Kramar, Roy Lau, David A. Boothman>, James S. Economou, Keith L. Black, Adenovirus-mediated p53 gene delivery potentiates the radiation-induced growth inhibition of experimental brain tumors. Journal of Neuro-oncology. ,vol. 37, pp. 217- 222 ,(1998) , 10.1023/A:1005924925149
G Reifenberger, K Ichimura, V P Collins, E E Schmidt, CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Research. ,vol. 54, pp. 6321- 6324 ,(1994)
Jin Jen, J Wade Harper, Sandra H Bigner, Darell D Bigner, Nickolas Papadopoulos, Sanford Markowitz, James KV Willson, Kenneth W Kinzler, Bert Vogelstein, None, Deletion of p16 and p15 Genes in Brain Tumors Cancer Research. ,vol. 54, pp. 6353- 6358 ,(1994)
Joseph F. Costello, Mitchel S. Berger, H-J. Su Huang, Webster K. Cavenee, Silencing of p16/CDKN2 Expression in Human Gliomas by Methylation and Chromatin Condensation Cancer Research. ,vol. 56, pp. 2405- 2410 ,(1996)
Gaetano Finocchiaro, Cristiana Giani, Mutation Rate of the CDKN2 Gene in Malignant Gliomas Cancer Research. ,vol. 54, pp. 6338- 6339 ,(1994)
Liliana Soroceanu, Richard J. Whitley, James M. Markert, Bernard Roizman, Edward R. Flotte, G. Yancey Gillespie, Joany Chou, Samita Andreansky, Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors. Cancer Research. ,vol. 57, pp. 1502- 1509 ,(1997)
M. Ramachandra, I. W. Cheney, M.-T. Vaillancourt, S. T. C. Neuteboom, R. Bookstein, Adenovirus-mediated gene transfer of MMAC1/PTEN to glioblastoma cells inhibits S phase entry by the recruitment of p27Kip1 into cyclin E/CDK2 complexes. Cancer Research. ,vol. 59, pp. 2318- 2323 ,(1999)
Candelaria Gomez-Manzano, W. K. Alfred Yung, Kim D. Steck, Jack A. Roth, Juan Fueyo, Victor A. Levin, Peter A. Steck, Timothy J. McDonnell, Athanassios P. Kyritsis, Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis. Cancer Research. ,vol. 56, pp. 694- 699 ,(1996)
Frederic Preffer, David Dombkowski, Jeffrey S. DeFrank, Stephen Friend, Simon N. Powell, Wei Tang, Paul Connell, Maeve Eogan, Differential Sensitivity of p53(-) and p53(+) Cells to Caffeine-induced Radiosensitization and Override of G2 Delay Cancer Research. ,vol. 55, pp. 1643- 1648 ,(1995)